OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting a lineage-specific PI3Kɣ–Akt signaling module in acute myeloid leukemia using a heterobifunctional degrader molecule
Loïs Kelly, Justine C. Rutter, Kevin Lin, et al.
Nature Cancer (2024) Vol. 5, Iss. 7, pp. 1082-1101
Closed Access | Times Cited: 7
Loïs Kelly, Justine C. Rutter, Kevin Lin, et al.
Nature Cancer (2024) Vol. 5, Iss. 7, pp. 1082-1101
Closed Access | Times Cited: 7
Showing 7 citing articles:
Targeting PI3Kγ in cancer
Giuliana P. Mognol, Anghesom Ghebremedhin, Judith A. Varner
Trends in cancer (2025)
Open Access
Giuliana P. Mognol, Anghesom Ghebremedhin, Judith A. Varner
Trends in cancer (2025)
Open Access
A metabolic synthetic lethality of phosphoinositide 3-kinase-driven cancer
Guillaume P. Andrieu, Mathieu Simonin, Aurélie Cabannes‐Hamy, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Guillaume P. Andrieu, Mathieu Simonin, Aurélie Cabannes‐Hamy, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Recent advances in targeted degradation in the RAS pathway
Zhiming Ge, Zisheng Fan, Wei He, et al.
Future Medicinal Chemistry (2025), pp. 1-16
Closed Access
Zhiming Ge, Zisheng Fan, Wei He, et al.
Future Medicinal Chemistry (2025), pp. 1-16
Closed Access
Inhibiting PI3Kγ in acute myeloid leukemia
Aaron J. Stonestrom, Ross L. Levine
Nature Cancer (2024) Vol. 5, Iss. 7, pp. 958-959
Closed Access | Times Cited: 1
Aaron J. Stonestrom, Ross L. Levine
Nature Cancer (2024) Vol. 5, Iss. 7, pp. 958-959
Closed Access | Times Cited: 1
Targeting Pregnane X Receptor with a Potent Agonist-Based PROTAC to Delay Colon Cancer Relapse
Lucile Bansard, Guillaume Laconde, V. Delfosse, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Lucile Bansard, Guillaume Laconde, V. Delfosse, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Noncanonical PI3Kγ signaling addiction is a therapeutic target in a subset of leukemias
Yu Zhang, Qian Kong, Yonglong Zhang
The Innovation (2024) Vol. 5, Iss. 6, pp. 100706-100706
Open Access
Yu Zhang, Qian Kong, Yonglong Zhang
The Innovation (2024) Vol. 5, Iss. 6, pp. 100706-100706
Open Access
Oleanolic acid 28-O-β-D-glucopyranoside: A novel therapeutic agent against ulcerative colitis via anti-inflammatory, barrier-preservation, and gut microbiota-modulation
Caixia Wang, Hanlin Liu, Zhuoqiao Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117534-117534
Closed Access
Caixia Wang, Hanlin Liu, Zhuoqiao Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117534-117534
Closed Access
